Dopamine transporter ligands: recent developments and therapeutic potential
about
Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporterDevelopment of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications.Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection.Randomized trial comparing two treatment strategies using prize-based reinforcement of abstinence in cocaine and opiate users.Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.Further structure-activity relationship studies on 8-substituted-3-[2-(diarylmethoxyethylidenyl)]-8-azabicyclo[3.2.1]octane derivatives at monoamine transporters.A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.Monoamine transporters: vulnerable and vital doorkeepers.Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters.Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease.The synthesis of bivalent 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)-8-heterobicyclo[3.2.1]octanes as probes for proximal binding sites on the dopamine and serotonin transporters.Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription.A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization.CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders.The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.
P2860
Q24644993-502CCD7C-BB9F-4ADE-8912-B1F2B16F2A9EQ33738377-54FDEACC-5899-4723-A97D-14099DEBB9ECQ34136977-A8DB8719-9BC5-4FF4-A112-9FCB4962374AQ34153285-4B54C741-7C19-48AE-A8AC-1A98E01CB8BBQ34899113-7F0BFDDC-2C18-4C1C-B2B3-47C4F5D0D861Q34936945-177F13F7-E77F-47F8-B24B-C1C5DFA82D75Q34986560-FDCB784B-4399-4612-A1BF-A52B3BC54CF8Q35089573-D05A357A-BE51-489F-8F13-252E618C2711Q35590737-63ED90A6-1A01-4CAB-9891-9A36402209C7Q35671408-50EE2B09-59B5-44F0-A0C9-46D6077B46D5Q35877150-1CB3FE0E-CF59-4F7C-85B9-F87316949C4CQ35939405-B9802B9C-C50F-4BED-9A5F-B1CA92884E37Q36154790-7C78C70F-FDCB-4D02-83D1-9087DC633039Q36571393-DCFAFB1B-0F42-489C-A466-EAC5C15638D8Q36980311-556E6C23-7C18-47B8-8140-ABFA4D16E7D8Q37003610-D3AFD70E-A90C-4CF3-80C1-9C57706F3885Q37460264-11DD7656-F4EE-4DD2-BBA3-024C550C3142Q38811823-3D8B1ACF-9645-40D0-844E-B5932032AB3DQ39851539-A6710AD0-1286-4D76-8E52-1466DE5648C5Q42439159-511D53F9-12D5-45A9-8A8B-732017486BB0Q46043227-4A99B7E2-CD37-4C07-B3AD-AFDDC55D165BQ48141734-EFD868B2-AE70-4E98-8D3F-104CA5C83A65Q48156370-63A9C7F9-D90A-4927-A775-8AFEEE466F29
P2860
Dopamine transporter ligands: recent developments and therapeutic potential
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dopamine transporter ligands: recent developments and therapeutic potential
@ast
Dopamine transporter ligands: recent developments and therapeutic potential
@en
Dopamine transporter ligands: recent developments and therapeutic potential
@nl
type
label
Dopamine transporter ligands: recent developments and therapeutic potential
@ast
Dopamine transporter ligands: recent developments and therapeutic potential
@en
Dopamine transporter ligands: recent developments and therapeutic potential
@nl
prefLabel
Dopamine transporter ligands: recent developments and therapeutic potential
@ast
Dopamine transporter ligands: recent developments and therapeutic potential
@en
Dopamine transporter ligands: recent developments and therapeutic potential
@nl
P1476
Dopamine transporter ligands: recent developments and therapeutic potential
@en
P2093
F Ivy Carroll
Scott P Runyon
P304
P356
10.2174/156802606778249775
P407
P577
2006-01-01T00:00:00Z